Where Will Cassava Sciences Be in 1 Year?

Where Will Cassava Sciences Be in 1 Year?

Submitted by admin on January 7, 2022 - 10:45am
Source: 
Motley Fool
News Tags: 
Cassava Sciences
Simulfilam
clinical trials
Alzheimer's disease
Headline: 
Where Will Cassava Sciences Be in 1 Year?
snippet: 
  • Cassava Sciences' stock has outperformed the market in 2021, thanks to its leading pipeline candidate, Simufilam.
  • The biotech is running two phase 3 studies for the investigational medicine for Alzheimer's disease.
  • Although Simufilam has delivered so far, there's a long road ahead for the therapy.

Do Not Allow Advertisers to Use My Personal information